Galantos Pharma
Mainz
About Galantos Pharma
Galantos Pharma GmbH focuses on the development of drugs for the treatment of Alzheimer's and other neurodegenerative diseases. It develops a drug for the treatment of mild-to-moderate Alzheimer's dementia. The company develops a technology platform that is suitable for screening and preclinical validation of drug candidates that are acting on cholinergic and other neuro-receptors and on various brain enzymes. The company was founded in 2005 and is based in Mainz, Germany.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $13.9M
- Funding stage: M&A
- Last round: Series C (May 2010)
- Website: galantos.com
- Phone: 49 6131 1440 311
Industries & Categories
Biopharma, Biotechnology, Health Care, Pharmaceutical
Canonical: https://fsome.com/organization/galantos-pharma-1944748 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.